Subscribe To
Eli lilly: miracle drug progress offers shareholders more upside
Eli Lilly and Company continues to make impressive progress when it comes to its obesity and diabetes medications. Shares have already shot up in rece...
June 30, 2023, 10:23 pm
Are oil bears missing supply risks ahead?
Geopolitical pressures loom over oil supply and pricing heading into the second half of 2023. Claudio Galimberti, Rystad Energy SVP and Head of Americ...
June 30, 2023, 8:00 pm
Weekly focus – two-sided risks ahead for h2
The first half of 2023 was characterized by economic growth surprising to the upside, but also inflation proving stickier than expected. As such, when...
June 30, 2023, 2:19 pm
Coca-cola femsa: earnings growth continues, valuation still appealing amid softer momentum
The Consumer Staples sector has the lowest percentage of sell-side 'buy' ratings among the 11 S&P 500 sectors, but Coca-Cola FEMSA (KOF) is considered...
June 30, 2023, 2:16 pm
Enact holdings: being shareholder friendly offers upside
Enact Holdings is viewed as a relatively defensive position with well-managed risks and commitment to s...
June 30, 2023, 2:03 pm
Weekly market wrap with gary thomson: gbp/eur, aapl all-time high, gold drop
Get the latest scoop on the week's hottest headlines, all in one convenient video. Join Gary Thomson, the COO of FXOpen UK, as he breaks down the most...
June 30, 2023, 1:36 pm
The case against nvidia stock
Over the past two months, Nvidia Corporation's market capitalization has ballooned over $300 billion. Geopolitical and regulatory...
June 30, 2023, 1:30 pm
Goldman sachs is still a high quality buy
Goldman Sachs has strong fundamentals, attractive valuation, and growth opportunities, particularly in its wealth management and alternative assets se...
June 30, 2023, 1:25 pm
Strong team aids charles river (crai) amid currency risks
A strong professional team and shareholder-friendly policies bode well for Charles River Associates (CRAI). Currency and liquidity...
June 30, 2023, 12:12 pm
New zealand’s central bank does not want crypto regulations
The Reserve Bank of New Zealand issued a statement today (Friday) to notify its intention to increase the monitoring of stablecoins and crypto assets....
June 30, 2023, 10:00 am
Amgen: a healthcare bargain with a 4% yield
Despite facing regulatory challenges and competition from biosimilar products, biotech giant Amgen is seen as an attractive investment opportunity due...
June 30, 2023, 8:25 am
Growth risks to restrain oil prices this year
Oil prices will struggle for traction this year as global economic headwinds stymie gains that could be fuelled by a rebound in China and OPEC+ cuts, ...
June 30, 2023, 7:08 am
Xyld: why covered calls on the s&p 500 is a bad strategy
The Global X S&P 500 Covered Call ETF is structured to replicate a covered call option strategy on the underlying S&P 500 Index. We explore the cover...
June 30, 2023, 6:23 am
Usd/jpy to move back to 135 on a six-month view as boj makes a step towards altering ycc – rabobank – fxstreet
Information on these pages contains forward-looking statements that involve risks and uncertainties. Ma...
June 30, 2023, 5:29 am
New mountain finance: growing dividends with further potential upside
New Mountain Finance is benefiting from the higher interest rate environment, leading to increased quarterly dividend payments and the launch of a sup...
June 30, 2023, 1:13 am
Xrp bears eye sub-$0.45 on hawkish fed bets and sec v ripple news
It is a busy day for XRP and the broader market, with ETF news and US economic indicators in focus. However, downside...
June 30, 2023, 1:02 am
Reserve bank of new zealand is ramping up its monitoring of stablecoins and cryptoassets
The RBNZ says there are significant risks and opportunities from stablecoins and other private money in...
June 30, 2023, 12:41 am
Mercer international: might just be enough for a dividend investment
Mercer International is expected to yield around 4% annually and has the potential for growth and compounding returns in the long run, despite the vol...
June 30, 2023, 12:41 am
Aud/usd price analysis: bulls stay in the game and eye higher before correction – fxstreet
Information on these pages contains forward-looking statements that involve risks and uncertainties. Ma...
June 30, 2023, 12:29 am
Scpharmaceuticals: oversold territory, drug launch still looks robust
scPharmaceuticals' Furoscix dose-filling rates increased by 55% month over month in May. Despite the lower figures than market expectations, SCPH stoc...
June 29, 2023, 11:05 pm